Remarkably, when an increase in melanoma is detected in specific subgroups of patients, it does not appear to correlate with a decline in CD4 + T cell count at diagnosis or general immune suppression, and SIR does not increase over time after diagnosis [88, 93]. Here, CD4 is linked to melanoma.